The Blavatnik Fund for Innovation at Yale

Since 2017, the Blavatnik Fund for Innovation at Yale has awarded approximately $28 million to 116 technologies, helping launch 52 startups that have raised nearly $517 million in external funding.

The Blavatnik Fund for Innovation at Yale is a $65 million fund, committed to cultivating and transforming Yale’s pioneering research into cutting-edge, life-saving solutions within the realm of life sciences. The Fund is made possible by a generous grant from the Blavatnik Family Foundation in support of the commercialization of Yale faculty applied research and technology in the life sciences. The Fund’s integrated approach combines business expertise, intensive guidance, and essential funding to support innovative, Yale investigator-initiated translational research. Completed projects will be better positioned to positively impact human health through startup advancement, partnerships with industry, major industry-sponsored research agreements, and/or external non-dilutive funding.

To date, four Blavatnik-funded assets have advanced to the clinic across nine clinical trials, and four Blavatnik-backed startups have been acquired.